Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2008
02/07/2008US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative
02/07/2008US20080032995 Aldh-2 inhibitors in the treatment of drug addiction
02/07/2008US20080032994 adducts of 2,6-di-tert-butyl-4-methylphenol (BHT) with azole compounds, e.g. ketoconazole, itraconazole, pramiconazole; skin fungal disorder associated with Trichophyton, Candida, Pityrosporum or Malassezia, or bacterial disorder associated with Staphylococci, Streptococci or Propionbacterium acnes
02/07/2008US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents
02/07/2008US20080032974 Compounds and therapeutical use thereof
02/07/2008US20080032964 Process for the synthesis of azetidinone
02/07/2008CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008CA2659689A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
02/07/2008CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy
02/06/2008EP1883451A2 Substituted indole compounds having nos inhibitory activity
02/06/2008EP1135239B1 Wood preservative formulations
02/06/2008CN101119989A Chroman derivatives and uses thereof
02/06/2008CN101119970A Azadecalin glucocorticoid receptor modulators
02/06/2008CN100366612C 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors
02/05/2008US7326799 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
02/05/2008US7326792 4,5-Diphenyl-2-amino-4,5-dihydro-imidazole derivatives useful as pharmaceutical agents in treatment or prevention of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease
02/05/2008US7326784 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
02/05/2008US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
02/05/2008US7326721 Doxepin analogs and methods of use thereof
02/05/2008US7326720 Phenyl- and pyridylpiperidines with TNF activity
02/05/2008US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
02/05/2008US7326712 Substituted tricyclic compounds as protein kinase inhibitors
02/05/2008US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent
02/05/2008US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs
02/05/2008CA2281642C Substituted 2,4-diaminopyrimidines
02/05/2008CA2205406C Novel benzyl pyrimidines
01/2008
01/31/2008WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
01/31/2008WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors
01/31/2008WO2008012246A1 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same
01/31/2008WO2008012234A2 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same
01/31/2008WO2008012227A2 Pyrazoles as glucokinase activators
01/31/2008WO2008011742A1 Method of using organic compounds
01/31/2008US20080027226 Electroluminescent Device
01/31/2008US20080027112 enzyme inhibitors of phosphodiesterase 4; antiinflammatory agent for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines
01/31/2008US20080027076 Pyrimidines With Tie2 (Tek) Activity
01/31/2008US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis
01/31/2008US20080027056 Substituted heterocyclic ethers and their use in cns disorders
01/31/2008US20080027055 1-Substituted indoles, and benzimidazoles additionally substituted with an amino ligand, e.g., 1-[(5-chlorothien-2-yl)sulfonyl]-5-[2-(piperidin-1-yl)ethoxy]-1H-indole; treating schizophrenia, depression, attention deficit disorder, Alzheimer's disease and Parkinson's disease
01/31/2008US20080027054 4-Substituted quinolines as antitumor agents
01/31/2008US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio)
01/31/2008US20080027049 Benzofurans as potassium ion channel modulators
01/31/2008US20080026478 providing a dye 2-[(E)-2-(8-Dihexylamino-2-hydroxy-4,5-dioxo-4H,5H-pyrano[3,2-c]chromen-3-yl)-vinyl]-3,3-dimethyl-5-sulfo-1-(3-sulfo-propyl)-3H-indolium sodium salt or it's chelate compound and a biocompatible excipient to stain the protein by forming protein-dye complex
01/31/2008CA2657566A1 Pyrazoles as glucokinase activators
01/31/2008CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors
01/30/2008EP1881978A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
01/30/2008EP1881977A1 Histone deacetylase inhibitors
01/30/2008EP1881976A1 Substituted amide derivatives as protein kinase inhibitors
01/30/2008EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
01/30/2008EP1881974A2 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
01/30/2008EP1881966A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
01/30/2008EP1881830A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
01/30/2008CN101115746A Novell processes for the preparation of a benzofuran
01/30/2008CN101115745A Mitotic kinesin inhibitors
01/30/2008CN101115744A Process for the preparation of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline,their intermediates and crystalline salts thereof
01/30/2008CN101115743A Novel processes for the preparation of a 2H-chromene
01/30/2008CN101115736A Potassium channel modulating agents and their medical use
01/30/2008CN101115734A Spiro derivatives as lipoxygenase inhibitors
01/30/2008CN101115732A Sulfonyl pyrrolidines, method for producing the same and their use as drugs
01/30/2008CN101115728A Triazole substituted aminobenzophenone compounds
01/30/2008CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands
01/30/2008CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
01/30/2008CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors
01/29/2008US7323573 Production of polyketides
01/29/2008US7323570 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,antitumor agents
01/29/2008US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
01/29/2008US7323488 Chromogenic enzyme substrates
01/29/2008US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase
01/29/2008US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection
01/29/2008US7323464 Kinase inhibitors; autoimmune disease; antiinflammatory agents
01/29/2008US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia
01/29/2008US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis
01/29/2008CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments
01/29/2008CA2255620C Novel anandamide amidase inhibitors as analgesic agents
01/24/2008WO2008011392A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation
01/24/2008WO2008011117A2 Antiviral protease inhibitors
01/24/2008WO2008010455A1 METHOD FOR PRODUCING β-DIARYL ELECTRON-WITHDRAWING GROUP SUBSTITUTED COMPOUND
01/24/2008WO2008009741A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
01/24/2008WO2008009691A1 Pyrimidine derivatives and their use as pesticides
01/24/2008WO2008009406A1 Novel pyridazine derivatives
01/24/2008WO2008009405A2 Novel pyridazine derivatives
01/24/2008WO2007135131A8 Substituted pyrazinone derivatives for use as a medicine
01/24/2008WO2007133597A9 Crystalline form of atorvastatin calcium stable after storage
01/24/2008WO2007128086A3 Novel viral replication inhibitor
01/24/2008WO2007126957A3 New compounds
01/24/2008WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists
01/24/2008US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay
01/24/2008US20080021070 Pyridine derivatives, preparation and therapeutic application thereof
01/24/2008US20080021061 Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
01/24/2008US20080021053 Heterocyclic Derivatives
01/24/2008US20080021042 Composition For Controlling Neuropathic Pain
01/24/2008US20080021030 Substituted Pyrazoles As Ppar Agonists
01/24/2008US20080021025 Inhibitors of cathepsin s
01/24/2008US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
01/24/2008US20080021011 Therapeutic compounds
01/24/2008US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis
01/24/2008US20080016674 Method And Installation Means For Installing An Electrical Machine
01/24/2008DE102006032164A1 Substituierte Furyl-sulfonylamino(thio)carbonyl-triazolin(thi)one Furyl substituted-sulfonylamino (thio) carbonyl-triazolin (ethi) ones
01/24/2008CA2659524A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
01/24/2008CA2658254A1 Novel pyridazine derivatives
01/24/2008CA2657936A1 Antiviral protease inhibitors